About: Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1997 (uk) article scientifique publié en 1997 (fr) im Juli 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1997 (ast) scientific article published on 01 July 1997 (en)
publication date	wds:Q73551668-804711CB-4245-4FA4-9A6E-2581D33D3F8D
publication date	1997-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73551668-13437CEA-F940-4686-A9E7-1921B21C4A98
language of work or name	English
cites work	wds:Q73551668-1673F7F4-21B9-4585-8D15-559FD3688546 wds:Q73551668-30A8B262-20A1-476B-ABAB-E8F3F5344D4D wds:Q73551668-339AE1A3-67FD-44CB-8B17-40B0CDCAA30F wds:Q73551668-595AEA99-6F42-430C-B7FB-9CBF870A7FDD wds:Q73551668-5F71B647-E14F-456B-AFAA-4ADD8BD0AE06 wds:Q73551668-847588C7-E6BE-49A6-9CD4-32CE1223F5B0 wds:Q73551668-92756B13-7C2B-49D5-A243-4B4359B5B67F wds:Q73551668-96217719-1D81-41C9-8D07-73DFC6BAA32C wds:Q73551668-A45D4EDC-244E-40BF-AA07-409DEB0F42B8 wds:Q73551668-A9A222A1-2D40-47CB-93C7-DED009DBE663 wds:Q73551668-AD6328E4-E48F-4060-B88C-E79116D2D9AB wds:Q73551668-BE534488-24E4-4AE7-99B9-A4C9485C9C0F wds:Q73551668-C40AB994-3706-4E2D-AD4A-F607C8CB77EC wds:Q73551668-C67BBB36-DB9C-4BB4-944D-EC5F9A820743 wds:Q73551668-DD2C2157-AB26-4A8B-AC2C-A7006A219D21 wds:Q73551668-FE096562-A5B4-4AD6-BD7E-80C9B2542A5F
cites work	Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer Correlation of pathologic findings with progression after radical retropubic prostatectomy Radical surgery versus radiotherapy for adenocarcinoma of the prostate The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy. The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients. Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma
author name string	wds:Q73551668-58EC2E51-C343-440A-B9B6-1848A84149CF wds:Q73551668-683FF496-F36C-4A8D-89C7-8E9DAA8821C5 wds:Q73551668-6ABDF0AF-D396-4630-B09A-E1B0F024D5F2 wds:Q73551668-710BD6C9-05D8-420F-ABB1-D63B9AB8ACFE wds:Q73551668-93D9DAD2-BC43-4F46-BB86-DF0E7BDF8EF4
author name string	H S Levin E A Klein P A Kupelian C D Zippe D Keyser
rdfs:label	Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? (en) Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? (nl)
skos:prefLabel	Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? (en) Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? (nl)
name	Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? (en) Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? (nl)
title	wds:Q73551668-82CC5453-9B7B-4C00-8A88-5AAA1C90C5C6
title	Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? (en)
page(s)	wds:Q73551668-8678E1E9-CD04-48F8-8748-D9B7B519A4F8
page(s)	723-729
instance of	wds:Q73551668-20274003-7481-447C-A291-5AFD75B0F73E
instance of	scholarly article
main subject	wds:Q73551668-8F6676C9-3199-4BE2-8188-1FBC44C8E3D9
main subject	prostate cancer
PubMed ID	wds:Q73551668-635E986A-900D-437D-BD58-AAEE6932E255
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9240638
PubMed ID	9240638
published in	wds:Q73551668-3F9A3041-A26A-4ABB-B10F-DA6C0B7B8AD9
published in	International Journal of Radiation Oncology Biology Physics
issue	wds:Q73551668-2F37567F-DAA0-4645-9076-FE6C906F66B1
volume	wds:Q73551668-91FCC738-BF7A-4F20-8681-E3BFBF4E34F7
issue	4
volume	38
DOI	wds:Q73551668-82D1141C-F28B-4A59-9624-5DA29A5513D2
DOI	http://dx.doi.org/10.1016/S0360-3016(97)00123-5
DOI	10.1016/S0360-3016(97)00123-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73551668
is cites work of	An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up Radiation therapy or prostatectomy: an old conflict revisited in the PSA era. A radiation oncologist's viewpoint A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes Update on the treatment of prostate cancer with external beam irradiation Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage Prostate cancer: a comprehensive review Comparison of three radiotherapy treatment planning protocols of definitive external-beam radiation for localized prostate cancer Radiation therapy versus radical prostatectomy in the PSA era: a urologist's view Prostate-specific antigen to predict outcome of external beam radiation for prostate cancer: Walter Reed Army Medical Center experience, 1988-1995 Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer Impact of comorbidity in elderly prostate cancer patients treated with brachytherapy Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. Primary radiation therapy for localized prostate cancer Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity [Treatments of prostate carcinoma and imaging follow up] Radical prostatectomy versus radiation therapy for clinically localized prostate carcinoma: the butcher and the baker selling their wares Results of radiation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: comparison of two different definitions of PSA failure.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software